A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy

BACKGROUND: Fatigue is common among glioma patients undergoing radiotherapy (RT) and impacts quality of life (QOL). We evaluated whether armodafinil, a wakefulness-promoting medication, improves fatigue in glioma patients undergoing RT. METHODS: Eligibility criteria included age ≥18 years, Karnofsky...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Lee, Eudocia Q., Muzikansky, Alona, Drappatz, Jan, Kesari, Santosh, Wong, Eric T., Fadul, Camilo E., Reardon, David A., Norden, Andrew D., Nayak, Lakshmi, Rinne, Mikael L., Alexander, Brian M., Arvold, Nils D., Doherty, Lisa, Stefanik, Jennifer, LaFrankie, Debra, Ruland, Sandra F., Pulverenti, Julee, Smith, Katrina H., Gaffey, Sarah C., Hammond, Samantha, Wen, Patrick Y.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
Clinical Investigations
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4864265/
https://ncbi.nlm.nih.gov/pubmed/26902850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now007
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki